Latest profit margin for Penumbra: 10.67% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), PEN shows a profit margin of 10.67%. That compares with 11.54% in the prior-year period — down 7.5% year over year. That is below the Healthcare sector average of 13.89%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PEN's profit margin is now 10.67% (was 11.54%) — a 7.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Penumbra is outperforming or lagging.
The Healthcare sector average profit margin is about 13.89%. Penumbra is at 10.67%, which is lower that average. That is roughly 23.2% below the sector mean. Use the comparison chart on this page to see how PEN stacks up against individual peers as well.
That compares with 11.54% in the prior-year period — down 7.5% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Penumbra with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Penumbra's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 10.67%) with ownership activity and broader fundamentals.